Target intelligence / Profile preview

Bulk extracellular fluid (ECF)

Target
ECF
Molecular classification
Other, Physiological compartment, Non-protein target
01

Overview

Bulk extracellular fluid (ECF) represents the total volume of body water located outside of the cell membranes, including the interstitial fluid that bathes tissues and the plasma within the circulatory system (Guyton and Hall, 2020). It serves as the primary medium for the exchange of nutrients, gases, and metabolic wastes between the blood and the intracellular environment, thereby maintaining the stability of the internal milieu (StatPearls, 2023). In pharmacology, the ECF is recognized as a non-molecular target for therapeutic agents that exert their effects through physical or chemical changes rather than by binding to specific receptors or enzymes (NCBI, 2022). For instance, osmotic diuretics such as mannitol are administered to increase the osmolality of the ECF, which draws water out of swollen tissues like the brain or eye (PubChem, 2024). Similarly, systemic alkalinizing agents like sodium bicarbonate are used to neutralize excess hydrogen ions in the ECF to treat metabolic acidosis (StatPearls, 2023). Because the ECF is a broad physiological compartment, drugs targeting it can significantly impact fluid balance and electrolyte concentrations, necessitating careful clinical monitoring (NIH, 2023).

Other names
Extracellular fluidInterstitial fluidExtracellular compartmentExtracellular matrix fluid
02

Mechanism of action

Drugs targeting the bulk extracellular fluid act through non-specific physical or chemical mechanisms, such as the modulation of osmotic pressure to redistribute water or the chemical neutralization of acids to regulate pH levels.

03

Biological functions

Osmotic balancepH regulationNutrient transportWaste removalElectrolyte homeostasisSignal transduction medium
04

Disease associations

EdemaDehydrationAcidosisAlkalosisElectrolyte imbalanceCongestive heart failure
05

Safety considerations

Fluid overloadElectrolyte disturbancesPulmonary edemaMetabolic alkalosisHypernatremia
06

Interacting drugs

Mannitol

4 more in the full profile.

07

Biomarkers

Serum osmolalityBlood pHSerum electrolytes (Na+, K+, Cl-)Bicarbonate concentration

Beyond the preview

Go deeper on Bulk extracellular fluid (ECF).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bulk extracellular fluid (ECF).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call